Spero Therapeutics (SPRO) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to -$869000.0.
- Spero Therapeutics' Change in Receivables rose 5736.02% to -$869000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 27713.31%. This contributed to the annual value of $1.5 million for FY2024, which is 23405.64% up from last year.
- According to the latest figures from Q3 2025, Spero Therapeutics' Change in Receivables is -$869000.0, which was up 5736.02% from $1.8 million recorded in Q2 2025.
- Spero Therapeutics' 5-year Change in Receivables high stood at $3.5 million for Q1 2024, and its period low was -$6.7 million during Q2 2021.
- Over the past 5 years, Spero Therapeutics' median Change in Receivables value was $38000.0 (recorded in 2021), while the average stood at -$215263.2.
- As far as peak fluctuations go, Spero Therapeutics' Change in Receivables tumbled by 120229.01% in 2023, and later skyrocketed by 73321.55% in 2025.
- Over the past 5 years, Spero Therapeutics' Change in Receivables (Quarter) stood at $38000.0 in 2021, then skyrocketed by 244.74% to $131000.0 in 2022, then tumbled by 1202.29% to -$1.4 million in 2023, then soared by 126.94% to $389000.0 in 2024, then crashed by 323.39% to -$869000.0 in 2025.
- Its last three reported values are -$869000.0 in Q3 2025, $1.8 million for Q2 2025, and -$2.4 million during Q1 2025.